Barclays PLC Veru Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Veru Inc. stock. As of the latest transaction made, Barclays PLC holds 184,777 shares of VERU stock, worth $116,409. This represents 0.0% of its overall portfolio holdings.

Number of Shares

184,777

Previous 184,777 -0.0%

Holding current value

$116,409

Previous $142,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$0.77 - $1.04 $107,505 - $145,201	139,617 Added 309.16%	184,777 $142,000
Q2 2024 Aug 14, 2024	BUY	$0.76 - $1.79 $34,321 - $80,836	45,160 New	45,160 $39,000
Q2 2023 Aug 03, 2023	SELL	$0.98 - $1.49 $32,043 - $48,718	-32,697 Reduced 99.86%	46 $0
Q1 2023 May 04, 2023	SELL	$1.16 - $6.41 $8,190 - $45,261	-7,061 Reduced 17.74%	32,743 $38,000
Q4 2022 Feb 13, 2023	BUY	$4.78 - $15.01 $177,094 - $556,105	37,049 Added 1344.79%	39,804 $210,000
Q3 2022 Nov 03, 2022	SELL	$10.22 - $23.7 $5,171 - $11,992	-506 Reduced 15.52%	2,755 $32,000
Q2 2022 Aug 12, 2022	SELL	$4.35 - $15.85 $46,736 - $170,292	-10,744 Reduced 76.72%	3,261 $37,000
Q1 2022 May 16, 2022	SELL	$4.55 - $6.41 $291,973 - $411,329	-64,170 Reduced 82.09%	14,005 $67,000
Q4 2021 Feb 14, 2022	BUY	$5.89 - $9.73 $305,425 - $504,549	51,855 Added 197.02%	78,175 $461,000
Q3 2021 Nov 09, 2021	BUY	$6.78 - $9.89 $124,236 - $181,224	18,324 Added 229.16%	26,320 $225,000
Q2 2021 Aug 13, 2021	SELL	$7.24 - $11.2 $273,092 - $422,464	-37,720 Reduced 82.51%	7,996 $64,000
Q1 2021 May 13, 2021	BUY	$8.05 - $20.78 $229,956 - $593,601	28,566 Added 166.57%	45,716 $493,000
Q4 2020 Feb 11, 2021	SELL	$2.36 - $9.99 $16,829 - $71,238	-7,131 Reduced 29.37%	17,150 $148,000
Q3 2020 Nov 12, 2020	SELL	$2.58 - $3.36 $7,270 - $9,468	-2,818 Reduced 10.4%	24,281 $63,000
Q2 2020 Aug 12, 2020	BUY	$3.01 - $4.02 $81,567 - $108,937	27,099 New	27,099 $90,000

Others Institutions Holding VERU

# of Institutions

122

Shares Held

56.9M

Call Options Held

668K

Put Options Held

531K

View Full List

About VERU INC.

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $50.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

More about VERU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account